Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Peter Anderson

Concepts (971)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-HIV Agents
203
2026
914
25.540
Why?
Pre-Exposure Prophylaxis
132
2026
272
20.270
Why?
HIV Infections
231
2026
3215
15.940
Why?
Tenofovir
125
2026
300
15.020
Why?
Emtricitabine
86
2026
209
11.320
Why?
Adenine
89
2026
339
10.730
Why?
Organophosphates
66
2026
179
7.510
Why?
Medication Adherence
79
2026
535
6.700
Why?
Alcoholic Beverages
12
2024
32
5.140
Why?
Alcohol Drinking
28
2025
850
4.320
Why?
Dried Blood Spot Testing
34
2026
129
4.150
Why?
Homosexuality, Male
47
2026
231
3.900
Why?
Beer
7
2023
13
3.730
Why?
Transgender Persons
38
2026
213
3.550
Why?
Drug Monitoring
26
2025
399
3.440
Why?
Lamivudine
15
2025
63
2.740
Why?
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
13
2025
19
2.730
Why?
Leukocytes, Mononuclear
29
2026
585
2.650
Why?
Tandem Mass Spectrometry
28
2026
576
2.630
Why?
Organophosphonates
14
2015
95
2.510
Why?
Zidovudine
14
2012
75
2.350
Why?
HIV-1
28
2025
913
2.300
Why?
Humans
391
2026
146342
2.240
Why?
Alcoholism
16
2022
830
2.230
Why?
Sexual and Gender Minorities
18
2024
269
2.170
Why?
Ethanol
10
2026
630
2.140
Why?
Primary Health Care
21
2023
1776
2.100
Why?
Consumer Behavior
5
2022
68
2.080
Why?
Commerce
7
2024
80
2.030
Why?
Adult
193
2026
41087
2.020
Why?
Antiviral Agents
17
2026
779
2.000
Why?
Female
253
2026
79499
1.940
Why?
Young Adult
114
2026
14330
1.930
Why?
Disease Transmission, Infectious
10
2018
69
1.900
Why?
Deoxycytidine
8
2015
219
1.890
Why?
Male
240
2026
73396
1.890
Why?
Chromatography, Liquid
21
2026
453
1.870
Why?
HIV Protease Inhibitors
14
2016
69
1.750
Why?
Oligopeptides
10
2015
264
1.720
Why?
Anti-Retroviral Agents
14
2023
250
1.520
Why?
Hair
10
2024
81
1.510
Why?
Deoxyadenine Nucleotides
3
2016
16
1.470
Why?
Deoxycytosine Nucleotides
3
2016
13
1.460
Why?
Thymine Nucleotides
6
2016
19
1.430
Why?
Prospective Studies
58
2026
8123
1.400
Why?
Alanine
15
2026
171
1.380
Why?
Middle Aged
115
2026
36619
1.360
Why?
Atazanavir Sulfate
9
2016
41
1.340
Why?
Adolescent
108
2026
22557
1.330
Why?
Pyridines
8
2024
610
1.310
Why?
Health Policy
6
2021
399
1.300
Why?
Polyphosphates
9
2026
46
1.290
Why?
Blood Chemical Analysis
11
2019
109
1.220
Why?
HIV Seropositivity
9
2023
118
1.180
Why?
Chemotherapy, Cancer, Regional Perfusion
3
2015
30
1.140
Why?
Reverse Transcriptase Inhibitors
15
2023
89
1.120
Why?
Food Industry
2
2020
8
1.120
Why?
Cephalexin
2
2025
14
1.100
Why?
Contraceptive Devices, Female
6
2026
14
1.090
Why?
Viral Load
18
2026
526
1.090
Why?
Cytidine Triphosphate
6
2023
19
1.070
Why?
Erythrocytes
7
2025
750
1.030
Why?
Alcohol-Related Disorders
4
2016
125
1.000
Why?
Cytochrome P-450 CYP3A
5
2012
93
1.000
Why?
Coinfection
7
2025
143
0.990
Why?
Public Policy
3
2022
79
0.990
Why?
HIV
13
2023
249
0.980
Why?
South Africa
20
2026
262
0.940
Why?
Wine
2
2023
13
0.930
Why?
Chemoprevention
7
2018
91
0.930
Why?
Micrognathism
2
2016
19
0.930
Why?
Sarcoma, Ewing
4
2023
103
0.920
Why?
Administration, Oral
19
2026
872
0.920
Why?
Osteogenesis, Distraction
2
2016
25
0.910
Why?
Interrupted Time Series Analysis
6
2022
73
0.860
Why?
Drug Interactions
19
2026
405
0.840
Why?
Drug Resistance, Viral
7
2025
127
0.830
Why?
Cross-Over Studies
10
2024
615
0.820
Why?
Product Labeling
2
2021
12
0.800
Why?
Phosphorous Acids
3
2024
15
0.790
Why?
Hyperthermia, Induced
3
2015
119
0.780
Why?
Pyrimidines
6
2026
532
0.770
Why?
Community Participation
2
2023
128
0.770
Why?
Substance-Related Disorders
5
2023
1100
0.770
Why?
Pharmacogenetics
4
2024
176
0.760
Why?
Delivery of Health Care
7
2023
947
0.750
Why?
Health Personnel
3
2022
754
0.750
Why?
Harm Reduction
2
2016
49
0.740
Why?
Circulating Tumor DNA
1
2023
50
0.740
Why?
Sexual Behavior
10
2026
490
0.730
Why?
Latin America
7
2026
96
0.720
Why?
Anti-Bacterial Agents
4
2025
1942
0.720
Why?
Mexico
11
2026
233
0.720
Why?
Pregnancy Complications, Infectious
7
2026
438
0.720
Why?
Scotland
4
2024
54
0.720
Why?
Dideoxynucleotides
7
2023
17
0.710
Why?
Rectum
4
2024
180
0.710
Why?
Directly Observed Therapy
3
2022
16
0.700
Why?
Health Services
1
2022
112
0.700
Why?
Postpartum Period
8
2026
377
0.690
Why?
Pregnancy Trimester, Second
2
2026
91
0.680
Why?
Forgiveness
1
2021
1
0.680
Why?
Cephalometry
2
2020
30
0.680
Why?
Indinavir
5
2006
7
0.670
Why?
Prenatal Exposure Delayed Effects
3
2026
665
0.670
Why?
Sustained Virologic Response
3
2025
48
0.670
Why?
Acquired Immunodeficiency Syndrome
3
2023
238
0.670
Why?
Pyridones
8
2023
210
0.660
Why?
Ritonavir
6
2012
76
0.660
Why?
Depression
8
2022
1575
0.640
Why?
Social Norms
2
2018
31
0.640
Why?
Hormones
2
2022
134
0.630
Why?
Diketopiperazines
8
2023
24
0.630
Why?
Acrocephalosyndactylia
5
2024
12
0.630
Why?
Viremia
9
2026
158
0.630
Why?
Internet
6
2017
660
0.630
Why?
Psychotherapy, Brief
3
2016
44
0.630
Why?
Kenya
11
2025
129
0.620
Why?
Drug Administration Schedule
12
2021
790
0.620
Why?
Pregnancy Trimester, Third
1
2020
117
0.620
Why?
Alcoholic Intoxication
3
2021
78
0.610
Why?
Desmoplastic Small Round Cell Tumor
3
2015
3
0.600
Why?
Preventive Health Services
2
2018
154
0.600
Why?
Solid Phase Extraction
4
2026
28
0.590
Why?
Text Messaging
6
2026
188
0.580
Why?
Head
1
2020
125
0.580
Why?
Biological Assay
2
2018
133
0.570
Why?
Pregnancy
22
2026
7230
0.570
Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2018
4
0.560
Why?
Biomarkers, Pharmacological
1
2018
26
0.560
Why?
Peru
8
2026
61
0.560
Why?
Europe
10
2025
421
0.560
Why?
Kidney Function Tests
3
2018
156
0.560
Why?
Referral and Consultation
6
2023
881
0.560
Why?
Dextromethorphan
1
2018
24
0.550
Why?
Cytochrome P-450 CYP2D6
1
2018
33
0.550
Why?
Pharmacogenomic Variants
1
2018
35
0.550
Why?
Brain Concussion
7
2025
660
0.550
Why?
Ultrasonography, Prenatal
1
2020
291
0.540
Why?
European Union
2
2017
13
0.540
Why?
Review Literature as Topic
1
2018
53
0.530
Why?
Iohexol
2
2015
23
0.530
Why?
Nucleosides
4
2022
25
0.510
Why?
General Practitioners
2
2014
26
0.510
Why?
Behavior, Addictive
1
2018
90
0.510
Why?
Microbial Sensitivity Tests
4
2025
367
0.510
Why?
Quality of Life
10
2025
3200
0.510
Why?
Training Support
1
2017
35
0.510
Why?
Post-Concussion Syndrome
5
2024
185
0.500
Why?
Child
41
2026
22693
0.500
Why?
Reproducibility of Results
17
2026
3416
0.500
Why?
Reimbursement, Incentive
1
2017
44
0.500
Why?
Glomerular Filtration Rate
5
2018
745
0.500
Why?
Health Care Costs
2
2018
423
0.500
Why?
Sexually Transmitted Diseases
4
2024
163
0.500
Why?
Mandible
2
2020
73
0.490
Why?
United Kingdom
5
2021
377
0.490
Why?
Deoxyguanine Nucleotides
1
2016
12
0.490
Why?
Cigarette Smoking
1
2018
103
0.490
Why?
Genitalia
1
2016
32
0.480
Why?
Hepatitis B virus
5
2024
33
0.480
Why?
Counseling
5
2026
406
0.480
Why?
Dermatitis, Atopic
3
2025
319
0.480
Why?
Memory, Short-Term
5
2019
276
0.480
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2023
1998
0.480
Why?
Desiccation
2
2014
26
0.470
Why?
Sofosbuvir
5
2022
63
0.470
Why?
Diphosphates
5
2021
20
0.470
Why?
Raltegravir Potassium
2
2015
18
0.470
Why?
Pierre Robin Syndrome
1
2016
16
0.460
Why?
Tobacco Products
1
2017
90
0.460
Why?
Infectious Disease Transmission, Vertical
3
2025
188
0.450
Why?
Cost of Illness
4
2025
323
0.450
Why?
Craniofacial Abnormalities
1
2016
78
0.440
Why?
Antitubercular Agents
3
2026
212
0.440
Why?
Bone Neoplasms
3
2023
272
0.440
Why?
Genitalia, Female
1
2015
43
0.440
Why?
Costs and Cost Analysis
4
2024
217
0.430
Why?
Sexual Partners
6
2024
195
0.430
Why?
Self Report
11
2024
870
0.430
Why?
Specimen Handling
2
2014
178
0.420
Why?
Antiretroviral Therapy, Highly Active
3
2015
278
0.420
Why?
Condoms
4
2021
99
0.420
Why?
Cefoxitin
1
2014
8
0.410
Why?
Cytoreduction Surgical Procedures
1
2015
69
0.410
Why?
Bone Density
5
2020
494
0.410
Why?
Lopinavir
2
2013
30
0.400
Why?
Gastroesophageal Reflux
1
2016
232
0.390
Why?
Rifampin
2
2026
80
0.390
Why?
Colombia
6
2023
41
0.390
Why?
Biomarkers
9
2025
4340
0.390
Why?
Peripartum Period
2
2024
19
0.390
Why?
Neoplasm Recurrence, Local
3
2023
1160
0.380
Why?
Infant, Newborn
14
2025
6460
0.380
Why?
Patient Compliance
9
2017
589
0.380
Why?
Netherlands
7
2024
85
0.380
Why?
Half-Life
7
2016
157
0.380
Why?
Immunologic Factors
1
2015
244
0.370
Why?
Child, Preschool
26
2025
11913
0.370
Why?
HIV Seronegativity
3
2010
28
0.360
Why?
Cross-Sectional Studies
14
2025
5899
0.360
Why?
Aged
27
2025
26432
0.360
Why?
Nontuberculous Mycobacteria
1
2014
189
0.360
Why?
Cisplatin
2
2013
347
0.360
Why?
Spodoptera
3
2024
39
0.350
Why?
Tuberculosis
2
2026
290
0.350
Why?
Social Support
4
2024
646
0.350
Why?
Longitudinal Studies
12
2026
3017
0.350
Why?
Healthy Volunteers
5
2019
218
0.350
Why?
Zimbabwe
7
2026
76
0.350
Why?
Treatment Outcome
21
2021
11821
0.340
Why?
Attitude of Health Personnel
3
2017
1219
0.340
Why?
Phosphates
2
2015
175
0.340
Why?
Bisexuality
2
2025
39
0.340
Why?
Unsafe Sex
4
2021
62
0.340
Why?
Polymorphism, Single Nucleotide
3
2024
2240
0.340
Why?
Ribavirin
4
2018
81
0.340
Why?
Infant
15
2025
10114
0.340
Why?
Wales
2
2021
24
0.330
Why?
Brazil
8
2026
179
0.330
Why?
Infant, Extremely Premature
2
2023
67
0.330
Why?
Sex Factors
10
2024
2107
0.330
Why?
Lymphocyte Activation
1
2015
1137
0.330
Why?
Executive Function
3
2024
463
0.330
Why?
Hepatitis B
4
2024
66
0.330
Why?
Neuropsychological Tests
5
2025
1149
0.330
Why?
Models, Biological
4
2026
1761
0.320
Why?
Pilot Projects
8
2025
1888
0.320
Why?
Chromatography, High Pressure Liquid
6
2026
588
0.320
Why?
Microsomes, Liver
1
2010
85
0.320
Why?
Patient Reported Outcome Measures
2
2025
516
0.320
Why?
Glycerophospholipids
3
2025
39
0.320
Why?
Health Knowledge, Attitudes, Practice
3
2021
1408
0.320
Why?
HIV Integrase Inhibitors
2
2021
80
0.320
Why?
Fetal Alcohol Spectrum Disorders
2
2026
74
0.320
Why?
Diabetic Nephropathies
1
2014
320
0.320
Why?
Risk-Taking
5
2019
321
0.310
Why?
Frontal Bone
2
2023
19
0.310
Why?
Peritoneal Neoplasms
2
2011
103
0.310
Why?
Combined Modality Therapy
7
2020
1271
0.310
Why?
Follow-Up Studies
14
2024
5439
0.310
Why?
Craniosynostoses
2
2024
69
0.310
Why?
Feeding Behavior
1
2016
692
0.310
Why?
Hepatitis C
4
2022
251
0.300
Why?
Drug Stability
7
2014
172
0.300
Why?
Carcinoma, Small Cell
1
2010
172
0.300
Why?
Macaca
4
2023
66
0.300
Why?
Inflammation
3
2022
2919
0.300
Why?
Mycobacterium Infections, Nontuberculous
1
2014
339
0.290
Why?
RNA, Viral
9
2023
693
0.290
Why?
Receptors, Odorant
2
2021
32
0.290
Why?
Family Characteristics
2
2021
203
0.290
Why?
Mobile Applications
2
2022
196
0.290
Why?
Nucleotides
3
2016
128
0.290
Why?
Uganda
6
2026
91
0.290
Why?
Liver Neoplasms
3
2021
776
0.290
Why?
Cerebral Palsy
2
2022
149
0.280
Why?
Airway Obstruction
3
2016
152
0.280
Why?
Hypothermia, Induced
1
2010
96
0.280
Why?
England
2
2021
106
0.280
Why?
Public Health
3
2023
574
0.280
Why?
Feasibility Studies
11
2025
1135
0.280
Why?
Central Nervous System Stimulants
2
2022
183
0.280
Why?
Retrospective Studies
14
2023
17438
0.280
Why?
Telemedicine
3
2024
966
0.280
Why?
Genotype
9
2024
1879
0.270
Why?
Clinical Trials as Topic
6
2019
1064
0.270
Why?
CD4 Lymphocyte Count
6
2015
280
0.270
Why?
Drug Therapy, Combination
12
2019
1036
0.270
Why?
Administration, Rectal
2
2024
14
0.270
Why?
Dose-Response Relationship, Drug
9
2017
2022
0.270
Why?
United States
21
2025
16136
0.260
Why?
Linear Models
5
2026
857
0.260
Why?
Metabolic Clearance Rate
4
2018
115
0.260
Why?
Body Fluids
5
2019
70
0.260
Why?
Drug Resistance, Multiple, Viral
2
2017
10
0.260
Why?
Time Factors
7
2025
7109
0.260
Why?
Moths
2
2024
45
0.260
Why?
Efficiency
2
2025
102
0.250
Why?
Mental Health Services
2
2025
450
0.250
Why?
Didanosine
2
2006
13
0.250
Why?
Global Health
2
2014
403
0.250
Why?
Lung Diseases
1
2014
787
0.250
Why?
Gonadal Steroid Hormones
1
2008
143
0.250
Why?
Testosterone
3
2025
419
0.250
Why?
Osteosarcoma
2
2015
100
0.250
Why?
Kidney Calculi
1
2007
43
0.240
Why?
Placebos
8
2020
192
0.240
Why?
Animals
26
2025
38107
0.240
Why?
Achievement
3
2016
58
0.240
Why?
Cohort Studies
13
2026
6077
0.240
Why?
Radiosurgery
2
2021
398
0.240
Why?
Neoplasm Staging
4
2020
1488
0.240
Why?
Piperazines
2
2019
368
0.240
Why?
Underage Drinking
2
2016
22
0.240
Why?
Drug Combinations
3
2024
400
0.240
Why?
Students
2
2026
649
0.230
Why?
Isoniazid
1
2026
71
0.230
Why?
Age Factors
6
2021
3347
0.230
Why?
HIV Antibodies
3
2023
61
0.230
Why?
Case-Control Studies
7
2024
3647
0.230
Why?
Adenosine Monophosphate
1
2026
87
0.230
Why?
Sensitivity and Specificity
9
2016
1998
0.230
Why?
Sarcoma
2
2021
209
0.230
Why?
HIV Reverse Transcriptase
2
2012
32
0.230
Why?
Substantia Nigra
1
2026
64
0.230
Why?
Cranial Sutures
2
2023
16
0.230
Why?
Enterobacteriaceae
1
2025
44
0.220
Why?
Cyproterone Acetate
1
2025
2
0.220
Why?
Cognition
4
2025
1292
0.220
Why?
Alopecia Areata
1
2025
12
0.220
Why?
Polymorphism, Genetic
4
2016
612
0.220
Why?
Spectrometry, Mass, Electrospray Ionization
3
2018
175
0.220
Why?
Benchmarking
3
2024
193
0.220
Why?
Mental Disorders
3
2025
1148
0.220
Why?
Gene Expression
2
2009
1463
0.220
Why?
Fluorenes
3
2020
46
0.220
Why?
Carrageenan
1
2024
8
0.220
Why?
Australia
8
2022
291
0.220
Why?
Patient Acceptance of Health Care
4
2024
881
0.220
Why?
Anxiety
4
2022
1125
0.220
Why?
CD4-Positive T-Lymphocytes
4
2023
1150
0.220
Why?
Quinolones
2
2024
204
0.220
Why?
Hematocrit
2
2016
108
0.210
Why?
Cognition Disorders
3
2018
559
0.210
Why?
Hope
1
2024
31
0.210
Why?
Recovery of Function
2
2025
725
0.210
Why?
Program Evaluation
3
2022
952
0.210
Why?
Cefadroxil
1
2024
8
0.210
Why?
Epidemics
1
2025
97
0.210
Why?
Sex Attractants
1
2024
3
0.210
Why?
Hepatitis C, Chronic
3
2019
150
0.210
Why?
Surveys and Questionnaires
9
2025
6073
0.200
Why?
Benzimidazoles
3
2020
191
0.200
Why?
Point-of-Care Systems
2
2023
185
0.200
Why?
Gestational Age
4
2021
990
0.200
Why?
Macaca nemestrina
1
2023
29
0.200
Why?
Abdominal Neoplasms
2
2015
48
0.200
Why?
Area Under Curve
6
2019
335
0.200
Why?
Spain
3
2018
50
0.190
Why?
Oxytocin
1
2004
51
0.190
Why?
Delayed-Action Preparations
4
2026
192
0.190
Why?
Incidence
8
2025
2936
0.190
Why?
Iron
1
2026
359
0.190
Why?
Infant, Extremely Low Birth Weight
1
2023
24
0.190
Why?
Drug Carriers
1
2024
138
0.190
Why?
South Australia
2
2020
4
0.190
Why?
Motivational Interviewing
2
2022
121
0.190
Why?
Antineoplastic Agents
2
2013
2219
0.190
Why?
Chemotherapy, Adjuvant
2
2015
429
0.180
Why?
Radiotherapy, Intensity-Modulated
2
2015
143
0.180
Why?
Estradiol
5
2025
517
0.180
Why?
Olfactory Receptor Neurons
2
2017
42
0.180
Why?
Neoplasms
3
2015
2954
0.180
Why?
Mental Health
3
2024
779
0.180
Why?
Cost-Benefit Analysis
3
2026
640
0.180
Why?
Policy Making
1
2022
83
0.180
Why?
Calibration
2
2013
154
0.180
Why?
Survival Rate
4
2015
2092
0.180
Why?
Depressive Disorder
2
2021
361
0.170
Why?
Cell Phone
1
2022
83
0.170
Why?
Alcoholics
1
2021
2
0.170
Why?
Escherichia coli Infections
2
2013
125
0.170
Why?
Sex Workers
1
2021
12
0.170
Why?
Temperature
2
2016
635
0.170
Why?
Blood Platelets
1
2025
382
0.170
Why?
Creatinine
3
2018
511
0.170
Why?
Magnetic Phenomena
1
2021
10
0.170
Why?
Motor Skills Disorders
1
2021
23
0.170
Why?
Plasma
3
2015
222
0.170
Why?
Feedback, Psychological
1
2021
23
0.170
Why?
Parental Leave
1
2021
27
0.170
Why?
New York City
1
2021
89
0.170
Why?
Cystic Fibrosis
2
2022
1164
0.170
Why?
Ethambutol
1
2021
27
0.170
Why?
Restaurants
1
2021
25
0.170
Why?
Heterosexuality
1
2021
49
0.170
Why?
Schools
4
2021
436
0.170
Why?
Bariatric Surgery
1
2025
250
0.160
Why?
Predictive Value of Tests
4
2019
2113
0.160
Why?
Breast Feeding
1
2025
447
0.160
Why?
Sulfonamides
3
2011
594
0.160
Why?
Cord Blood Stem Cell Transplantation
1
2022
103
0.160
Why?
Meningitis, Cryptococcal
1
2021
34
0.160
Why?
Recombinant Proteins
2
2017
1361
0.160
Why?
Haplotypes
3
2012
506
0.160
Why?
Urocanic Acid
1
2020
1
0.160
Why?
Communicable Disease Control
1
2021
88
0.160
Why?
Cytokines
2
2008
2081
0.160
Why?
Semen
1
2000
21
0.160
Why?
Parents
3
2021
1394
0.160
Why?
Diabetes Mellitus, Type 1
2
2015
3930
0.160
Why?
Azithromycin
1
2021
101
0.160
Why?
Early Diagnosis
3
2016
251
0.160
Why?
Smell
2
2021
129
0.160
Why?
Single-Blind Method
4
2026
313
0.160
Why?
Maxillofacial Development
1
2020
20
0.160
Why?
Mycobacterium avium-intracellulare Infection
1
2021
63
0.160
Why?
Vagina
4
2025
202
0.160
Why?
Intimate Partner Violence
1
2022
93
0.160
Why?
Poland
2
2017
34
0.160
Why?
Emergency Service, Hospital
5
2025
2363
0.160
Why?
Vaginal Creams, Foams, and Jellies
1
2020
4
0.160
Why?
Probenecid
1
2019
8
0.150
Why?
Income
1
2021
206
0.150
Why?
Cluster Analysis
3
2016
496
0.150
Why?
Pandemics
3
2023
1707
0.150
Why?
Metronidazole
1
2019
20
0.150
Why?
Monitoring, Ambulatory
1
2020
88
0.150
Why?
Drug Design
1
2020
180
0.150
Why?
Pharmaceutical Preparations
1
2021
172
0.150
Why?
Drug Utilization
2
2017
171
0.150
Why?
Severity of Illness Index
5
2025
2921
0.150
Why?
Neutrophils
1
2025
1133
0.150
Why?
Drug Delivery Systems
2
2023
377
0.140
Why?
Directive Counseling
2
2016
48
0.140
Why?
Social Class
1
2021
260
0.140
Why?
Point-of-Care Testing
1
2019
36
0.140
Why?
Thailand
3
2025
20
0.140
Why?
Bayes Theorem
1
2021
426
0.140
Why?
Stavudine
1
2018
6
0.140
Why?
Mass Screening
3
2023
1307
0.140
Why?
Blood Vessels
1
2020
164
0.140
Why?
Reference Values
1
2020
796
0.140
Why?
Contrast Media
2
2015
493
0.140
Why?
Infusions, Intravenous
2
2014
432
0.140
Why?
Qualitative Research
2
2024
1734
0.140
Why?
Therapeutic Equivalency
1
2018
31
0.140
Why?
Renal Insufficiency
2
2018
173
0.140
Why?
Vitrification
1
2018
7
0.140
Why?
Cryoprotective Agents
1
2018
11
0.140
Why?
Blood Proteins
1
2000
239
0.140
Why?
Liquid Phase Microextraction
1
2018
2
0.140
Why?
Disease Models, Animal
4
2024
4580
0.140
Why?
Capsules
1
2018
40
0.140
Why?
Infusion Pumps, Implantable
1
2018
26
0.140
Why?
Fiber Optic Technology
1
1998
23
0.140
Why?
Pelvic Neoplasms
2
2015
24
0.140
Why?
Antibodies, Neutralizing
1
2021
348
0.140
Why?
Randomized Controlled Trials as Topic
5
2026
1763
0.140
Why?
Sexually Transmitted Diseases, Viral
1
2018
11
0.130
Why?
Chemistry Techniques, Analytical
1
2018
20
0.130
Why?
Nanomedicine
1
2018
47
0.130
Why?
Neuroprotective Agents
1
2019
146
0.130
Why?
Insulin-Like Growth Factor I
1
2020
320
0.130
Why?
Breast Neoplasms
3
2017
2418
0.130
Why?
Lab-On-A-Chip Devices
1
2018
63
0.130
Why?
Drug Compounding
1
2018
106
0.130
Why?
Administration, Intravaginal
3
2025
19
0.130
Why?
Legislation, Drug
1
2018
73
0.130
Why?
Intubation, Gastrointestinal
1
1998
76
0.130
Why?
Mucus
1
1998
75
0.130
Why?
Appendicitis
1
2019
151
0.130
Why?
ADAM Proteins
1
2017
65
0.130
Why?
Substrate Specificity
1
2018
389
0.130
Why?
Mucous Membrane
1
2018
130
0.130
Why?
Spine
1
2019
184
0.130
Why?
Carbamates
2
2009
52
0.130
Why?
Arthropod Antennae
1
2017
4
0.130
Why?
Antibodies, Monoclonal
2
2023
1512
0.130
Why?
Prognosis
3
2018
4351
0.130
Why?
Developmental Disabilities
1
2020
281
0.130
Why?
Impulsive Behavior
1
2019
146
0.130
Why?
Genes, MDR
1
2017
3
0.130
Why?
Child Development
3
2020
481
0.130
Why?
Cryopreservation
1
2018
115
0.130
Why?
Kidney
5
2016
1498
0.130
Why?
Eosinophil Peroxidase
1
2017
7
0.130
Why?
Anti-Infective Agents
1
2020
234
0.130
Why?
Double-Blind Method
5
2021
2070
0.130
Why?
Matrix Metalloproteinase 9
1
2017
128
0.130
Why?
Insect Proteins
1
2017
38
0.130
Why?
General Practice
2
2014
32
0.120
Why?
Phosphorylation
4
2015
1724
0.120
Why?
Macaca mulatta
3
2023
188
0.120
Why?
Bone Diseases
1
2017
60
0.120
Why?
Gels
2
2015
86
0.120
Why?
Bronchoscopy
1
1998
227
0.120
Why?
Clinical Studies as Topic
1
2016
12
0.120
Why?
Parietal Bone
1
2016
9
0.120
Why?
Seroconversion
3
2022
48
0.120
Why?
Quality Control
2
2015
163
0.120
Why?
Enzymes
1
2017
60
0.120
Why?
Inosine
1
2016
14
0.120
Why?
Blood Pressure Determination
1
2017
143
0.120
Why?
Nocturia
1
2016
8
0.120
Why?
Sweden
1
2017
114
0.120
Why?
Aptitude Tests
1
2016
4
0.120
Why?
Absorptiometry, Photon
4
2019
278
0.120
Why?
Guanosine
1
2016
40
0.120
Why?
Direct-to-Consumer Advertising
1
2016
8
0.120
Why?
Vitamin D Deficiency
1
2018
189
0.120
Why?
Peroxidase
1
2017
168
0.120
Why?
Acute Disease
1
2019
1038
0.120
Why?
Blastocystis Infections
1
1996
1
0.120
Why?
Computer Simulation
2
2021
1014
0.120
Why?
Health Status
2
2025
827
0.120
Why?
Reference Standards
2
2020
176
0.120
Why?
Professional Role
2
2015
172
0.120
Why?
Twist-Related Protein 1
2
2020
8
0.120
Why?
Quality Improvement
1
2025
1354
0.120
Why?
Intersectoral Collaboration
1
2016
64
0.120
Why?
Purine-Nucleoside Phosphorylase
2
2006
6
0.110
Why?
Methanol
1
2016
43
0.110
Why?
Biological Transport
1
2017
424
0.110
Why?
Exercise
2
2025
2213
0.110
Why?
Spermatozoa
1
2016
103
0.110
Why?
Bone and Bones
1
2018
319
0.110
Why?
Comorbidity
4
2021
1665
0.110
Why?
Solutions
1
2016
160
0.110
Why?
Life Expectancy
1
2016
72
0.110
Why?
Aged, 80 and over
5
2021
8391
0.110
Why?
Cyclohexanes
1
2015
21
0.110
Why?
Premature Birth
2
2017
390
0.110
Why?
Guidelines as Topic
2
2017
267
0.110
Why?
Neovascularization, Pathologic
1
2017
287
0.110
Why?
Population Dynamics
1
2016
142
0.110
Why?
Antibiotic Prophylaxis
1
2016
140
0.110
Why?
AIDS-Related Opportunistic Infections
1
1996
130
0.110
Why?
Brain Neoplasms
2
2017
1325
0.110
Why?
Phenotype
3
2019
3206
0.110
Why?
Medication Reconciliation
1
2015
31
0.110
Why?
Postoperative Period
1
2016
355
0.110
Why?
Interdisciplinary Communication
1
2016
200
0.110
Why?
Urinary Tract Infections
2
2017
209
0.110
Why?
Blood
1
2015
107
0.110
Why?
Liver Cirrhosis, Alcoholic
1
2014
18
0.110
Why?
Health Promotion
3
2022
786
0.110
Why?
Adenosine
1
2016
256
0.110
Why?
Down-Regulation
1
2017
614
0.110
Why?
Maxillofacial Injuries
1
2014
1
0.110
Why?
Athletic Injuries
2
2019
575
0.110
Why?
Saliva
1
2016
256
0.110
Why?
Brain Damage, Chronic
1
2014
17
0.110
Why?
Intracellular Space
1
2014
64
0.110
Why?
Simian Acquired Immunodeficiency Syndrome
1
2015
93
0.100
Why?
Injections, Intramuscular
2
2021
140
0.100
Why?
Attention
1
2018
463
0.100
Why?
Motivation
2
2016
605
0.100
Why?
Skull Fractures
1
2014
36
0.100
Why?
Victoria
3
2023
23
0.100
Why?
Antibiotics, Antitubercular
2
2026
35
0.100
Why?
Community Health Services
1
2016
229
0.100
Why?
Treatment Failure
3
2025
361
0.100
Why?
Triazoles
1
2015
190
0.100
Why?
Virulence Factors
2
2013
175
0.100
Why?
Respiratory Tract Infections
1
1998
403
0.100
Why?
Prevalence
5
2021
2861
0.100
Why?
Eating
1
2016
386
0.100
Why?
Mortality
1
2016
375
0.100
Why?
Regression Analysis
4
2019
999
0.100
Why?
Risk Assessment
3
2018
3712
0.100
Why?
Colorectal Neoplasms
1
2021
874
0.090
Why?
Health Status Disparities
1
2016
322
0.090
Why?
Delivery of Health Care, Integrated
1
2016
305
0.090
Why?
T-Lymphocyte Subsets
1
2015
416
0.090
Why?
Spironolactone
2
2023
40
0.090
Why?
Multivariate Analysis
3
2016
1543
0.090
Why?
Infant, Premature
1
2017
622
0.090
Why?
Carrier State
1
2013
80
0.090
Why?
Water
1
2016
451
0.090
Why?
Administration, Topical
2
2015
154
0.090
Why?
Sleep Deprivation
1
2015
207
0.090
Why?
Tumor Microenvironment
1
2017
747
0.090
Why?
Mutation
5
2025
4093
0.090
Why?
Lymphatic Metastasis
1
2013
335
0.090
Why?
Uropathogenic Escherichia coli
1
2011
4
0.090
Why?
Histone Demethylases
2
2023
39
0.090
Why?
Organic Anion Transporters
1
2011
13
0.090
Why?
Diabetes Mellitus
1
2020
1101
0.090
Why?
Cystitis
1
2011
24
0.090
Why?
Pravastatin
1
2011
45
0.090
Why?
Florida
2
2026
117
0.090
Why?
Proline
1
2012
79
0.090
Why?
Anion Exchange Resins
1
2011
8
0.090
Why?
Fibrosis
1
2014
568
0.080
Why?
Data Collection
1
2014
650
0.080
Why?
Endothelial Cells
1
2017
876
0.080
Why?
California
2
2026
475
0.080
Why?
Multiplex Polymerase Chain Reaction
1
2011
56
0.080
Why?
Membrane Proteins
1
2017
1130
0.080
Why?
Colonic Polyps
1
2012
87
0.080
Why?
Decision Making
1
2019
993
0.080
Why?
Patient Education as Topic
1
2016
770
0.080
Why?
Smoking
1
2018
1486
0.080
Why?
Risk Factors
8
2019
10921
0.080
Why?
Metabolic Detoxication, Phase I
1
2010
6
0.080
Why?
Continuity of Patient Care
1
2013
298
0.080
Why?
Food-Drug Interactions
1
2010
11
0.080
Why?
Phylogeny
3
2024
924
0.080
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
35
0.080
Why?
Antacids
1
2010
16
0.080
Why?
Pyrrolidinones
1
2010
29
0.080
Why?
Nuclear Proteins
2
2020
740
0.080
Why?
T-Lymphocytes
2
2018
2012
0.080
Why?
Adenoma
1
2012
210
0.080
Why?
Infusions, Parenteral
1
2010
47
0.080
Why?
Magnetic Resonance Imaging
4
2026
3926
0.080
Why?
Colonic Neoplasms
1
2012
259
0.080
Why?
Osteogenesis
2
2023
205
0.080
Why?
Survival Analysis
2
2010
1378
0.080
Why?
Epithelial Cells
1
2016
1119
0.080
Why?
Bluetongue
1
2009
6
0.080
Why?
Memory Disorders
1
2011
198
0.080
Why?
Colonoscopy
1
2012
257
0.080
Why?
Immunotherapy
1
2015
671
0.080
Why?
Escherichia coli Proteins
1
2011
200
0.080
Why?
Cattle Diseases
1
2009
19
0.080
Why?
Taxes
1
2009
16
0.070
Why?
Wounds and Injuries
2
2016
959
0.070
Why?
Social Marketing
1
2009
14
0.070
Why?
Tablets
2
2022
41
0.070
Why?
Kaplan-Meier Estimate
3
2021
970
0.070
Why?
Molecular Structure
1
2010
484
0.070
Why?
Information Services
1
2009
42
0.070
Why?
DNA-Binding Proteins
1
2016
1468
0.070
Why?
Lipid Metabolism
2
2018
533
0.070
Why?
DNA, Viral
2
2024
354
0.070
Why?
Mice, Knockout
3
2023
3125
0.070
Why?
Escherichia coli
1
2013
832
0.070
Why?
Immunity, Cellular
1
2010
277
0.070
Why?
Hypertension
1
2017
1272
0.070
Why?
Germany
2
2021
139
0.070
Why?
DNA Primers
2
2006
487
0.070
Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2008
28
0.070
Why?
Los Angeles
2
2019
73
0.070
Why?
Tracheal Diseases
1
2008
15
0.070
Why?
Politics
1
2009
89
0.070
Why?
Transcription Factors
1
2016
1730
0.070
Why?
Cities
2
2020
140
0.070
Why?
Liver
3
2013
1864
0.070
Why?
Demography
2
2022
274
0.070
Why?
Interviews as Topic
2
2024
930
0.070
Why?
Research Design
1
2014
1143
0.070
Why?
Colorado
1
2018
4595
0.070
Why?
Polymerase Chain Reaction
2
2013
1031
0.070
Why?
Pheromones
2
2024
22
0.070
Why?
Hospitalization
1
2018
2475
0.070
Why?
Mice
6
2024
18297
0.070
Why?
Gadolinium DTPA
1
2008
70
0.070
Why?
DNA
1
2014
1421
0.070
Why?
Embryonic Development
2
2020
124
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2011
449
0.060
Why?
Lung Neoplasms
2
2021
2675
0.060
Why?
Sleep
1
2015
896
0.060
Why?
Kinetics
1
2010
1553
0.060
Why?
Receptors, Pheromone
1
2006
3
0.060
Why?
Automobile Driving
1
2009
157
0.060
Why?
Binge Drinking
2
2018
44
0.060
Why?
Health Services Needs and Demand
1
2009
287
0.060
Why?
Oxidation-Reduction
1
2010
1075
0.060
Why?
Evidence-Based Practice
1
2009
231
0.060
Why?
Animal Communication
1
2006
18
0.060
Why?
Brain
1
2019
2991
0.060
Why?
Gene Products, vpr
1
2006
2
0.060
Why?
Dideoxynucleosides
1
2026
27
0.060
Why?
Acetylmuramyl-Alanyl-Isoglutamine
1
2006
12
0.060
Why?
Sequence Analysis, DNA
1
2009
771
0.060
Why?
Adipocytes
1
2008
223
0.060
Why?
Abnormalities, Multiple
1
2008
195
0.060
Why?
Pyrimidinones
1
2007
124
0.060
Why?
Electronic Health Records
1
2015
1210
0.060
Why?
Ifosfamide
1
2006
39
0.060
Why?
Hydrazines
1
2026
37
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
2
2019
266
0.060
Why?
School Health Services
1
2009
218
0.060
Why?
Limit of Detection
1
2026
92
0.060
Why?
Anti-Ulcer Agents
1
2006
12
0.060
Why?
Esomeprazole
1
2006
7
0.060
Why?
Health Education
1
2009
346
0.060
Why?
Pharmacology, Clinical
1
2006
9
0.060
Why?
Midwestern United States
1
2026
45
0.060
Why?
Base Sequence
2
2006
2123
0.060
Why?
Phosphatidylethanolamines
1
2006
78
0.060
Why?
Malawi
1
2026
58
0.060
Why?
Ribosomal Proteins
1
2006
93
0.060
Why?
Molecular Targeted Therapy
2
2020
447
0.060
Why?
Injections
1
2026
201
0.060
Why?
Education
1
2006
103
0.060
Why?
Proportional Hazards Models
2
2019
1331
0.060
Why?
Proton Pump Inhibitors
1
2006
101
0.060
Why?
Cytochrome P-450 Enzyme System
1
2006
163
0.060
Why?
Medical History Taking
2
2016
117
0.060
Why?
Methamphetamine
1
2026
75
0.060
Why?
Molecular Sequence Data
1
2009
2838
0.050
Why?
Drug Liberation
1
2025
36
0.050
Why?
World Health Organization
1
2005
104
0.050
Why?
Neoplasm Metastasis
2
2020
693
0.050
Why?
Herpesvirus 2, Human
1
2024
27
0.050
Why?
Lymphocytes
1
2007
379
0.050
Why?
Northern Territory
1
2024
4
0.050
Why?
Ghana
1
2024
43
0.050
Why?
Practice Patterns, Physicians'
1
2014
1408
0.050
Why?
Chitosan
1
2025
39
0.050
Why?
Lymphopenia
1
2004
62
0.050
Why?
Educational Status
2
2017
466
0.050
Why?
Multicenter Studies as Topic
1
2026
417
0.050
Why?
Polyesters
1
2025
76
0.050
Why?
International Cooperation
1
2005
193
0.050
Why?
Urea
1
2024
84
0.050
Why?
Protein Binding
2
2020
2244
0.050
Why?
Socioeconomic Factors
2
2019
1327
0.050
Why?
Deoxyadenosines
1
2023
7
0.050
Why?
Mitochondrial Proteins
1
2006
263
0.050
Why?
Canada
1
2025
432
0.050
Why?
Liposomes
1
2006
269
0.050
Why?
Proviruses
1
2023
16
0.050
Why?
Community Mental Health Services
1
2004
85
0.050
Why?
Drug Substitution
1
2024
62
0.050
Why?
Blood Glucose
1
2014
2360
0.050
Why?
Accidents, Traffic
2
2016
193
0.050
Why?
Canrenone
1
2023
1
0.050
Why?
Logistic Models
2
2019
2126
0.050
Why?
Meningitis, Bacterial
1
2004
52
0.050
Why?
Universities
1
2026
451
0.050
Why?
Immunoassay
1
2003
108
0.050
Why?
Disclosure
1
2023
91
0.050
Why?
Cell Movement
2
2017
951
0.050
Why?
Maximum Tolerated Dose
2
2015
217
0.050
Why?
Clinical Trials, Phase III as Topic
1
2022
116
0.050
Why?
Body Weight
2
2018
968
0.050
Why?
Saccharomyces cerevisiae Proteins
1
2006
411
0.050
Why?
Telephone
1
2023
175
0.040
Why?
Rilpivirine
1
2022
10
0.040
Why?
Blood Cells
1
2022
38
0.040
Why?
DNA-Directed RNA Polymerases
1
2022
60
0.040
Why?
Technology
1
2022
100
0.040
Why?
Benin
1
2021
6
0.040
Why?
Models, Statistical
2
2017
669
0.040
Why?
Policy
1
2023
147
0.040
Why?
Social Media
1
2024
159
0.040
Why?
Africa South of the Sahara
1
2021
56
0.040
Why?
Safe Sex
1
2021
24
0.040
Why?
Pruritus
1
2021
61
0.040
Why?
Sex Work
1
2021
23
0.040
Why?
Intention to Treat Analysis
1
2021
78
0.040
Why?
Risk
2
2021
920
0.040
Why?
Absenteeism
1
2021
51
0.040
Why?
Switzerland
1
2021
45
0.040
Why?
Re-Irradiation
1
2021
10
0.040
Why?
Trust
1
2023
160
0.040
Why?
Statistics, Nonparametric
1
2002
426
0.040
Why?
Siblings
1
2022
202
0.040
Why?
Immunotoxins
2
1991
51
0.040
Why?
Drug Resistance
1
2021
145
0.040
Why?
Feces
2
2011
496
0.040
Why?
Crisis Intervention
1
2021
34
0.040
Why?
Larva
1
2021
242
0.040
Why?
Glucuronides
1
2000
18
0.040
Why?
Feedback
1
2021
183
0.040
Why?
Mycobacterium avium Complex
1
2021
87
0.040
Why?
Wnt1 Protein
1
2020
8
0.040
Why?
Hepacivirus
1
2022
237
0.040
Why?
Papillomavirus Infections
1
2024
345
0.040
Why?
Sperm Motility
1
2020
34
0.040
Why?
Energy Metabolism
1
2006
930
0.040
Why?
Jumonji Domain-Containing Histone Demethylases
1
2020
64
0.040
Why?
Tissue Culture Techniques
1
2020
82
0.040
Why?
Protease Inhibitors
1
2020
103
0.040
Why?
Acyclovir
1
2000
97
0.040
Why?
Substance Abuse Detection
1
2021
110
0.040
Why?
Disease-Free Survival
2
2015
778
0.040
Why?
Lipodystrophy
1
1999
12
0.040
Why?
Bacteroides fragilis
1
2019
14
0.040
Why?
Fetal Blood
1
2022
325
0.040
Why?
Consensus
1
2022
467
0.040
Why?
Proof of Concept Study
1
2020
90
0.040
Why?
Staphylococcus aureus
1
2024
459
0.040
Why?
Health Surveys
1
2021
511
0.040
Why?
Radiation Injuries
1
2021
149
0.040
Why?
Soft Tissue Neoplasms
1
2021
133
0.040
Why?
Staphylococcal Infections
1
2024
397
0.040
Why?
Action Potentials
2
2017
500
0.040
Why?
Embryo, Mammalian
1
2020
230
0.040
Why?
North America
1
2020
300
0.040
Why?
Herpes Simplex
1
2000
103
0.040
Why?
Pregnancy Outcome
1
2023
503
0.040
Why?
Monte Carlo Method
1
2019
151
0.040
Why?
Hip
1
2019
61
0.040
Why?
Positron Emission Tomography Computed Tomography
1
2020
122
0.040
Why?
Intestine, Large
1
2018
13
0.030
Why?
Cartilage
1
2020
198
0.030
Why?
Hypoxia-Ischemia, Brain
1
2019
50
0.030
Why?
Cadherins
1
2020
202
0.030
Why?
Cell Proliferation
2
2020
2502
0.030
Why?
Uridine Monophosphate
1
2018
16
0.030
Why?
Luria-Nebraska Neuropsychological Battery
1
2018
1
0.030
Why?
Oils
1
2018
22
0.030
Why?
Dimethyl Sulfoxide
1
2018
42
0.030
Why?
Lymphoid Tissue
1
2019
82
0.030
Why?
Public Health Surveillance
1
2018
84
0.030
Why?
Cervix Uteri
1
2018
50
0.030
Why?
Safety
1
2020
347
0.030
Why?
Administration, Cutaneous
1
2018
128
0.030
Why?
Intensive Care Units, Neonatal
1
2021
295
0.030
Why?
Program Development
1
2020
371
0.030
Why?
Organic Anion Transport Protein 1
2
2008
6
0.030
Why?
Solvents
1
2018
112
0.030
Why?
Furans
2
2009
26
0.030
Why?
Lymphogranuloma Venereum
1
2017
1
0.030
Why?
Chondrocytes
1
2020
241
0.030
Why?
Hydrophobic and Hydrophilic Interactions
1
2018
194
0.030
Why?
Urinalysis
1
2018
82
0.030
Why?
Histones
1
2023
670
0.030
Why?
Cognitive Dysfunction
1
2024
481
0.030
Why?
Sleep Wake Disorders
1
2021
314
0.030
Why?
Vascular Endothelial Growth Factor A
1
2020
545
0.030
Why?
Nanotechnology
1
2018
114
0.030
Why?
Rats, Sprague-Dawley
1
2023
2537
0.030
Why?
Wechsler Scales
1
2017
60
0.030
Why?
Matrix Metalloproteinase 1
1
2017
22
0.030
Why?
Matrix Metalloproteinase 3
1
2017
27
0.030
Why?
Tomography, X-Ray Computed
2
2020
2786
0.030
Why?
Collagen Type IV
1
2017
26
0.030
Why?
Human Umbilical Vein Endothelial Cells
1
2017
106
0.030
Why?
Coculture Techniques
1
2017
245
0.030
Why?
Likelihood Functions
1
2017
138
0.030
Why?
Antigens, CD
1
2020
560
0.030
Why?
Practice Guidelines as Topic
2
2015
1591
0.030
Why?
Mammary Neoplasms, Experimental
1
2017
61
0.030
Why?
Equipment Design
1
2018
520
0.030
Why?
Odorants
1
2017
114
0.030
Why?
Membrane Transport Proteins
2
2008
154
0.030
Why?
Primary Cell Culture
1
2017
173
0.030
Why?
Defective Viruses
1
2016
5
0.030
Why?
USSR
1
2016
3
0.030
Why?
Cyclooxygenase 2
1
2017
166
0.030
Why?
X-Ray Microtomography
1
2016
117
0.030
Why?
Reaction Time
1
2018
438
0.030
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2016
59
0.030
Why?
Collagen Type I
1
2017
144
0.030
Why?
Hepatitis B, Chronic
1
2016
22
0.030
Why?
Breast
1
2017
155
0.030
Why?
Italy
1
2016
118
0.030
Why?
District of Columbia
1
2016
37
0.030
Why?
San Francisco
1
2016
60
0.030
Why?
Parathyroid Hormone
1
2016
118
0.030
Why?
Controlled Clinical Trials as Topic
1
2015
26
0.030
Why?
Drosophila
1
2017
168
0.030
Why?
Neuroectodermal Tumors
1
2015
1
0.030
Why?
Syphilis
1
2016
39
0.030
Why?
Skull
1
2016
162
0.030
Why?
Vitamin D
1
2018
402
0.030
Why?
Population
1
2015
30
0.030
Why?
Observer Variation
1
2016
356
0.030
Why?
Plant Preparations
1
2015
37
0.030
Why?
Gross Domestic Product
1
2014
1
0.030
Why?
Gonorrhea
1
2016
63
0.030
Why?
Filtration
1
2015
68
0.030
Why?
Nonlinear Dynamics
1
2015
96
0.030
Why?
Chlamydia Infections
1
2016
79
0.030
Why?
Membrane Glycoproteins
1
2017
495
0.030
Why?
Patient Discharge
1
2021
997
0.030
Why?
Liver Function Tests
1
2015
103
0.030
Why?
Diphtheria Toxin
2
1991
61
0.030
Why?
Abdomen
1
2015
142
0.030
Why?
Reproductive Health
1
2016
94
0.030
Why?
Clinical Protocols
1
2016
282
0.030
Why?
Africa
1
2015
119
0.030
Why?
Cell Line
1
2020
2814
0.030
Why?
Nonprescription Drugs
1
2015
68
0.030
Why?
Pelvis
1
2015
129
0.030
Why?
Cytoplasm
1
2015
253
0.030
Why?
Rats
1
2023
5586
0.030
Why?
Facial Bones
1
2014
28
0.030
Why?
Hepatocytes
1
2015
224
0.030
Why?
Forecasting
1
2016
388
0.030
Why?
Least-Squares Analysis
1
2014
73
0.030
Why?
Albuminuria
1
2015
190
0.030
Why?
Mice, Inbred BALB C
1
2017
1244
0.030
Why?
Cause of Death
1
2016
456
0.020
Why?
ROC Curve
1
2015
617
0.020
Why?
Adiposity
1
2018
533
0.020
Why?
Interleukin-2
2
1991
434
0.020
Why?
Vitamins
1
2015
183
0.020
Why?
Prescription Drugs
1
2015
110
0.020
Why?
Positron-Emission Tomography
1
2015
343
0.020
Why?
Intestinal Mucosa
1
2019
666
0.020
Why?
Lipids
1
2018
714
0.020
Why?
Health Plan Implementation
1
2014
143
0.020
Why?
Mitochondria
1
1999
997
0.020
Why?
Monocytes
1
2015
538
0.020
Why?
Sample Size
1
2013
124
0.020
Why?
Immunohistochemistry
1
2016
1712
0.020
Why?
Reimbursement Mechanisms
1
2013
79
0.020
Why?
Chi-Square Distribution
1
2013
517
0.020
Why?
New South Wales
1
2011
23
0.020
Why?
Inservice Training
1
2013
115
0.020
Why?
Recombinant Fusion Proteins
2
1991
663
0.020
Why?
Darunavir
1
2011
20
0.020
Why?
Neoplasm, Residual
1
2012
143
0.020
Why?
Proteins
1
2018
1022
0.020
Why?
Vinblastine
1
2011
75
0.020
Why?
Radiation-Sensitizing Agents
1
2011
43
0.020
Why?
Urine
1
2011
63
0.020
Why?
Recurrence
1
2015
1133
0.020
Why?
Dacarbazine
1
2011
98
0.020
Why?
Gene Expression Regulation, Developmental
1
2016
902
0.020
Why?
Fibroblasts
1
2017
1034
0.020
Why?
Radiotherapy Dosage
1
2011
289
0.020
Why?
Receptors, Antigen, T-Cell
1
2015
677
0.020
Why?
Physician Assistants
1
2013
102
0.020
Why?
Thiotepa
1
2010
21
0.020
Why?
Cyclophosphamide
1
2011
275
0.020
Why?
Camptothecin
1
2011
139
0.020
Why?
Bevacizumab
1
2011
169
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2011
150
0.020
Why?
Computer-Assisted Instruction
1
2011
69
0.020
Why?
Carmustine
1
2010
52
0.020
Why?
Models, Theoretical
1
2014
561
0.020
Why?
Dietary Supplements
1
2015
587
0.020
Why?
Transsexualism
1
2010
21
0.020
Why?
Nurse Practitioners
1
2013
141
0.020
Why?
Health Services Accessibility
1
2019
1107
0.020
Why?
Candida
1
2010
46
0.020
Why?
Interferons
1
2011
186
0.020
Why?
Carboplatin
1
2010
168
0.020
Why?
Nausea
1
2010
111
0.020
Why?
Ambulatory Care
1
2015
628
0.020
Why?
Thrombocytopenia
1
2011
206
0.020
Why?
Cholesterol
1
2011
411
0.020
Why?
Cell Line, Tumor
1
2017
3545
0.020
Why?
Transplantation, Autologous
1
2010
306
0.020
Why?
Body Mass Index
1
2018
2458
0.020
Why?
Epigenesis, Genetic
1
2014
712
0.020
Why?
Erythrocyte Transfusion
1
2011
226
0.020
Why?
Poisson Distribution
1
2009
77
0.020
Why?
Triglycerides
1
2011
527
0.020
Why?
Sex Characteristics
1
2015
801
0.020
Why?
Disease Progression
1
2017
2867
0.020
Why?
Prodrugs
1
2009
54
0.020
Why?
DNA Mutational Analysis
1
2009
410
0.020
Why?
Fatal Outcome
1
2008
302
0.020
Why?
Serum
1
2007
58
0.020
Why?
Point Mutation
1
2008
232
0.020
Why?
Immunosuppressive Agents
1
2012
829
0.020
Why?
Cattle
1
2009
940
0.020
Why?
Interferon-gamma
1
2010
781
0.020
Why?
Fatty Alcohols
1
2006
4
0.020
Why?
Electric Conductivity
1
2006
86
0.020
Why?
Platelet Count
1
2007
95
0.020
Why?
vpr Gene Products, Human Immunodeficiency Virus
1
2006
2
0.020
Why?
Gene Frequency
1
2008
496
0.020
Why?
Signal Transduction
1
2020
5246
0.020
Why?
Calorimetry
1
2006
69
0.010
Why?
Bacterial Proteins
1
2013
980
0.010
Why?
Quebec
1
2006
10
0.010
Why?
Ion Exchange
1
2006
2
0.010
Why?
Leukocyte Count
1
2007
321
0.010
Why?
Chemical Fractionation
1
2006
29
0.010
Why?
Software
1
2011
676
0.010
Why?
Mice, Inbred Strains
1
2006
384
0.010
Why?
Species Specificity
1
2006
543
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2011
992
0.010
Why?
Internationality
1
2006
156
0.010
Why?
Algorithms
2
2004
1849
0.010
Why?
Clinical Competence
1
2012
1272
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
846
0.010
Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2004
224
0.010
Why?
Alleles
1
2006
907
0.010
Why?
Cells, Cultured
1
2010
4118
0.010
Why?
Apoptosis
1
2010
2439
0.010
Why?
Adipose Tissue
1
2006
642
0.010
Why?
Shiga Toxins
2
1991
3
0.010
Why?
Mice, Transgenic
1
2006
2134
0.010
Why?
Bacterial Toxins
2
1991
110
0.010
Why?
Genetic Predisposition to Disease
1
2009
2488
0.010
Why?
Survivors
1
2004
526
0.010
Why?
Immunocompromised Host
1
2000
201
0.010
Why?
Diet
1
2006
1273
0.010
Why?
Protein Engineering
1
1990
122
0.000
Why?
Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)